[HTML][HTML] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

…, P Tober-Lau, D Hillus, P Schommers, C Lehmann… - Nature medicine, 2022 - nature.com
The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections across the
globe. This new variant of concern carries an unusually high number of mutations in key …

[HTML][HTML] Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

…, M Hallek, F Klein, I Suárez, C Lehmann - The Lancet Regional …, 2021 - thelancet.com
Background While the leading symptoms during coronavirus disease 2019 (COVID-19) are
acute and the majority of patients fully recover, a significant fraction of patients now …

[HTML][HTML] Swarm learning for decentralized and confidential clinical machine learning

…, F Kern, T Fehlmann, P Schommers, C Lehmann… - Nature, 2021 - nature.com
Fast and reliable detection of patients with severe and heterogeneous illnesses is a major
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel

…, RJ Landovitz, DM Smith, EF Eaton, C Lehmann… - Jama, 2023 - jamanetwork.com
Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new data, to …

[HTML][HTML] Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy …

…, A Jessen, S Ruzicic, T Kümmerle, C Lehmann… - The Lancet, 2019 - thelancet.com
Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

…, M Witmer-Pack, M Platten, C Lehmann… - Nature, 2015 - nature.com
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was
largely ineffective in pre-clinical and clinical settings and was therefore abandoned 1 , 2 , 3 . …

Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial

D Taubert, R Roesen, C Lehmann, N Jung, E Schömig - Jama, 2007 - jamanetwork.com
ContextRegular intake of cocoa-containing foods is linked to lower cardiovascular mortality
in observational studies. Short-term interventions of at most 2 weeks indicate that high doses …

[HTML][HTML] HIV-1 integration landscape during latent and active infection

…, BH Hahn, JL Czartoski, MJ McElrath, C Lehmann… - Cell, 2015 - cell.com
The barrier to curing HIV-1 is thought to reside primarily in CD4 + T cells containing silent
proviruses. To characterize these latently infected cells, we studied the integration profile of HIV…

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

…, L Nogueira, JA Pai, AL Butler, K Millard, C Lehmann… - Nature, 2018 - nature.com
Individuals infected with HIV-1 require lifelong antiretroviral therapy, because interruption of
treatment leads to rapid rebound viraemia. Here we report on a phase 1b clinical trial in …

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

…, TY Oliveira, GH Learn, YZ Cohen, C Lehmann… - Nature medicine, 2017 - nature.com
Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env)
protein. It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far. Here …